In his current role, Jim manages Crown Bioscience’s corporate partnerships in North America and Europe, which includes licensing in cell lines, organoid and PDX models from academic, non-profit and industry partners. His previous roles include Business Development at Crown Bioscience and other CROs, as well as Product Management and sales roles at both established as well as startup Life Science companies. Jim has an undergraduate degree in Biology from Holy Cross and an MBA from Boston College.